Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis. [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated the safety and effectiveness of Novantrone therapy followed by Copaxone in Relapsing-Remitting Multiple Sclerosis. The trial has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• COPAXONE (GLATIRAMER ACETATE)
• Novantrone (mitoxantrone)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Relapsing Remitting Multiple Sclerosis | Phase 2 | Status: COMPLETED